Pharmalot

Pharmalot By Ed Silverman

FTC seeks to block Illumina from buying Grail, citing threats to competition

Pharmalot By Ed Silverman

Most U.S. universities get an ‘F’ on ensuring access to drugs they discover

Pharmalot By Ed Silverman

Pharmalittle: Pfizer and BioNTech to boost Covid-19 vaccine production; lawmakers ask FTC to probe insulin pricing

Pharmalot By Ed Silverman

Canadian company pursues compulsory license to distribute Covid-19 vaccine to low-income countries

Pharmalot By Ed Silverman

Congressional lawmakers urge FTC to investigate insulin makers over their pricing

Pharmalot By Ed Silverman

Pharmalittle: White House eyes suspending patent rights on Covid-19 vaccines; J&J supplier may be a vaccine bottleneck

Pharmalot By Ed Silverman

Former top Lilly lobbyist sues the company for alleged sex discrimination and harassment

Pharmalot By Ed Silverman

Canada says drug spending keeps rising due to increasingly expensive specialty meds

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Novavax faces raw-materials shortages for Covid-19 shot; India curbs vaccine exports

Pharmalot By Ed Silverman

With time running out, an ALS patient fights with Biogen over expanded access to its drug

Pharmalot By Ed Silverman

EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance

Pharmalot By Ed Silverman

HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca revises Covid-19 vaccine effectiveness; contractors grab a big slice of vaccine revenues

Pharmalot By Ed Silverman

Pfizer hopes for a happy ending for an osteoarthritis drug with a troubled history

Pharmalot By Ed Silverman

Universities launch opioid litigation archive to ‘ensure history doesn’t repeat itself’

Pharmalot By Ed Silverman

Pharmalittle: Europe moves to curb Covid-19 vaccine exports; Slaoui fired from Galvani board over sexual harassment claim

Pharmalot By Ed Silverman

AbbVie accuses a company of recruiting an employee in order to steal Humira secrets

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca may have used ‘outdated’ info about its Covid-19 shot; Democrats eye drug-pricing measures

Pharmalot By Ed Silverman

Lawmakers introduce a bill to prevent Sacklers from using bankruptcy ‘loophole’ to evade liability

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca says studies show its Covid-19 vaccine is 79% effective; rich countries created vaccine inequity

Pharmalot By Ed Silverman

‘The public is being denied the truth’: A legal expert blasts Purdue’s bankruptcy plan to end opioid lawsuits

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Some European countries to resume use of AstraZeneca Covid-19 shot; Senate confirms Becerra as HHS secretary

Pharmalot By Ed Silverman

Does a drug’s name affect how patients and doctors perceive it? The FDA wants to know

Pharmalot By Ed Silverman

Antibiotic stewardship may be improving at U.S. hospitals, but new targets are still needed

Pharmalot By Ed Silverman

AmerisourceBergen say-on-pay proposal squeaks by amid outrage over CEO compensation

Pharmalot By Ed Silverman

Pharmalittle: Europe isn’t ruling out waiving IP rights for Covid-19 shots; AstraZeneca defends vaccine production process

Pharmalot By Ed Silverman

Pharma wins a round in a battle with HHS over a drug discount program for hospitals